Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON48993Terminated
Randomised trial of atomoxetine, donepezil and memantine, sponsored by University of Amsterdam. Primary endpoints: Behavioral reaction times, Behavioral performance scores and 3 more. Started May 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON48993.